How do you convert trials and signups at target accounts?

Last updated July 20, 2026

Trials at target accounts usually stall for one reason: the person using the trial isn't the person who can buy. To convert them, work both layers at once — help the trial user succeed digitally, and use direct mail to reach the decision-maker above them while the trial is still live. With B2BMail, you upload the account and the named budget holder, the business address is verified, and a FedEx Priority envelope lands the business case on their desk within days. Per-piece tracking tells your AE the day it arrives, so the 'your team is already evaluating us' conversation happens at peak trial momentum.

Key takeaways

  • A trial signup from a target account is a buying signal from the team — but usually not from the budget holder, who may not know the trial exists.
  • The conversion play is two-layer: nurture the trial user by email and in-product, and reach the economic buyer physically.
  • Speed matters — FedEx Priority puts materials on the decision-maker's desk in days, while the trial is still running.
  • Send the buyer a business case, not a feature tour: what their team is evaluating, why teams like theirs buy, and what it costs to decide slowly.
  • Reserve this play for genuine target accounts; mailing every self-serve signup makes no economic sense.

Why do trials at big accounts go nowhere?

In product-led motions, an engineer or manager at an enterprise signs up, pokes around, maybe even loves it — and then the trial expires because that person never had the authority or appetite to run an internal purchase. Emails to the trial user can't fix this, because the trial user isn't the blocker; the missing conversation is one or two levels up, with someone who has never heard of you.

That's precisely the person direct mail is good at reaching. Executives who ignore vendor email still open a FedEx envelope with their name on it — in B2BMail's experience, nearly all of them do.

The trial conversion play, step by step

Trigger this play when a signup or trial appears at an account on your target list, or when trial usage at any account crosses your qualification bar.

  • Identify the account from the signup and name the likely economic buyer — the manager, director, or VP above the trial user.
  • Upload that contact to B2BMail; the business address is found and verified.
  • Send a short executive letter and one-pager: their team is evaluating your product, here's the outcome teams like theirs get, here's the offer of a briefing. Upload your design or have B2BMail generate it.
  • The envelope ships FedEx Priority and lands on the buyer's desk — tracked, signature-backed, sent to a verified address.
  • The AE follows up the day tracking shows delivery, referencing both the envelope and the live trial.

What to send while a trial is running

The buyer envelope should answer the question 'why should I care that my team is trying this tool?' — a one-page business case in their language, a relevant customer story, and a concrete invitation such as a 20-minute briefing before the trial ends. Some teams also send the trial user something small and physical as encouragement; that's optional, and the decision-maker piece is the one that changes outcomes.

Timing is tight by design. A trial gives you a natural deadline, and FedEx Priority delivery in days — visible in the tracking dashboard — means the play fits inside even a 14-day window.

Honest fit: when not to run this

This play is for accounts where the ACV justifies human attention and a physical touch — your target list, or signups that clearly match your ideal profile. It's not for the long tail of self-serve signups, and it can't rescue a trial where the product didn't fit. It also works best when sales and product data are connected enough that you actually see target-account signups when they happen. B2BMail's no-contract, no-minimum model suits the naturally uneven volume of trial triggers.

Frequently asked questions

How do I find the decision-maker above a trial user?

Start with the trial user's company and team, then identify the relevant manager, director, or VP from your usual prospecting sources. You need a name and company — B2BMail finds and verifies the deliverable business address for the named contact before anything ships.

Won't the trial user feel like we went over their head?

Not if the message is framed as support rather than pressure — the letter celebrates that their team is evaluating the product and offers the buyer context, not a complaint. Many AEs also tell the trial user directly: 'we're sending your leadership a summary to make your case easier.' That turns the user into a champion instead of a bystander.

Is two weeks really enough time for direct mail?

Yes. B2BMail ships via FedEx Priority, which delivers in days, and every envelope has a real-time tracking ID. Triggered on day one or two of a trial, the envelope is on the buyer's desk with most of the trial window still ahead.

Should every product signup trigger a mailer?

No. Gate the play on account fit — target-list membership, ideal-profile match, or meaningful trial engagement. Direct mail costs more per touch than email, which is exactly why it should be spent on the signups that can become your largest deals.

Land on every prospect's desk

B2BMail puts your message in a FedEx envelope on the desk of every decision-maker at your target accounts — with per-piece tracking and every address verified before it ships.

Keep reading

ROI Calculator

Estimate your potential return on investment.

Responses

200

Deals

40.0

Revenue

$800,000

Campaign Cost*

$20,000

Net Impact

$780,000

ROI

3,900%

* Based on an average of $20 per envelope — enterprise discounts available.

Book a consultation today